William Robinson, pioneering virologist
Hard-driving molecular virologist who used ‘advanced chemistry to unlock the tightly held secrets of viruses’ was also a hearty mountain man, scaling peaks in Alaska and Nepal.
Screening for chronic kidney disease
Many people don’t know they have chronic kidney disease until it progresses. A new study by Stanford Medicine researchers finds that screening would increase life expectancy in a cost-effective way.
Forum rallies DEI agents for change
At the 2023 Stanford Medicine Diversity and Inclusion Forum, speakers emphasized communication that destigmatizes the patient, empowers frontline workers and supports non-English speaking patients.
Genes linked to brain cancer
An international effort led by a Stanford Medicine researcher finds more than 50 genes linked to glioma — a rare brain cancer. Although most gliomas are sporadic, a minority are inherited.
Reversing brain signals treats depression
A new study led by Stanford Medicine researchers is the first to reveal how magnetic stimulation treats severe depression: by correcting the abnormal flow of brain signals.
Synthetic biology and sustainability
Scientists gathered to discuss the future of synthetic biology and how it can help curb climate change and promote sustainability.
How beneficial fats increase lifespan
Fat from olive oil and nuts boosts the numbers of two key cellular structures and protects membranes from damage, lengthening the lives of laboratory worms, Stanford Medicine-led study finds.
Distracting videos ease kids’ radiotherapy
Most children receiving radiation therapy for cancer can hold still without anesthesia if they watch videos during the treatment, a study of a technique developed at Stanford Medicine found.
How statins improve vascular health
Statins designed to lower cholesterol have long been noted to work in mysterious ways to improve other aspects of cardiovascular health. A Stanford Medicine-led study uncovers how they do it.
Nobelists credit basic research
A two-day event at the Stanford School of Medicine brought together investors, regulators, company executives and scientists to discuss the most productive ways for them to work together.